抗補體成分4(C4)多克隆抗體
Anti-Complement Component 4 (C4) Polyclonal Antibody
- 編號UFAA888Mu01
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 激發(fā)波長-
- 單次使用量1-5 μl
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 且適物種Homo sapiens (Human，人)
- 應(yīng)用FCM
- 下載 英文說明書 中文說明書
- 規(guī)格 25test50test 100test 200test 500test
- 價格 ¥ 360 ¥ 600 ¥ 960 ¥ 1200 ¥ 2100
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
HepG2 human hepatocellular carcinoma cell line was stained with rabbit Anti-mouse C4 Polyclonal Antibody (Catalog # FAA888Mu01, filled red histogram) or Isotype control antibody (Catalog # IS067-Rb01, filled green histogram), followed by APC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog # SAA544Rb15). Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100.
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
用法
For flow cytometry, the suggested use of this reagent is 1-5 μl per 10^6 cells in 100 μl volume.
Optimal working dilutions could be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過一年。避免反復(fù)凍融。
贈品
相關(guān)產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPA888Mu02 | 補體成分4(C4)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA888Mu01 | 補體成分4(C4)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAA888Mu02 | 補體成分4(C4)多克隆抗體 | WB |
| UPAA888Mu01 | 補體成分4(C4)多克隆抗體 | WB |
| UFAA888Mu01 | 抗補體成分4(C4)多克隆抗體 | FCM |
| USEA888Mu | 補體成分4(C4)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCA888Mu | 補體成分4(C4)檢測試劑盒(化學發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMA888Mu | 補體成分4(C4)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Journal of Clinical Immunology | Complement activation contributes to the injury and outcome of kidney in human anti-glomerular basement membrane disease. [PubMed: 22941511] |
| British Journal of Pharmacology | The suppression of Brd4 inhibits peripheral plasma cell differentiation and exhibits therapeutic potential for systemic lupus erythematosus [] |
留言咨詢
